Blalock Williams’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.18M Sell
2,235
-4
-0.2% -$1.85K 0.77% 35
2026
Q1
$1.08M Buy
2,239
+63
+3% +$32.3K 0.83% 32
2025
Q4
$1.22M Buy
2,176
+321
+17% +$182K 0.98% 27
2025
Q3
$954K Buy
1,855
+109
+6% +$47.6K 0.84% 29
2025
Q2
$548K Buy
1,746
+33
+2% +$9.91K 0.55% 49
2025
Q1
$522K Buy
1,713
+573
+50% +$193K 0.58% 47
2024
Q4
$379K Buy
+1,140
New +$387K 0.44% 60

Other funds holding MEDP

Blalock Williams's MEDP Position: Q2 2026 in Review

Blalock Williams reduced its Medpace (MEDP) stake by 0.18% in Q2 2026, selling an estimated $1.85K and leaving 2,235 shares worth $1.18M. The position accounts for 0.77% of the portfolio, ranked #35.

Blalock Williams first reported a position in MEDP in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.22M in Q4 2025. 698 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Blalock Williams held 2,235 shares of Medpace worth $1.18M as of Q2 2026.
  • Blalock Williams sold 4 Medpace shares in Q2 2026, an estimated $1.85K.
  • Medpace made up 0.77% of Blalock Williams's portfolio in Q2 2026, its #35 holding.
  • Blalock Williams first reported a position in Medpace in Q4 2024 and has held it in 7 quarters since.
  • Blalock Williams's Medpace position peaked at $1.22M in Q4 2025.
  • 698 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Blalock Williams's 13F filing for Q2 2026, filed 7 Aug 2026.